Search for: "Chad Landmon" Results 1 - 2 of 2
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2009, 9:55 pm
Chad Landmon and Matt Becker of Axinn, Veltrop & Harkrider LLP will provide a comparison of competing follow-on biologics legislation and demonstrate the major differences between the bills, discuss the potential impact of this legislation on innovator biologics manufacturers, describe how patent challenges to biologics will be different from small molecule drugs, offer practical strategies for building the strongest possible patent portfolios, and provide information on… [read post]
17 Jun 2009, 2:18 am
We asked Chad Landmon, an intellectual property litigation partner at Axinn, Veltrop & Harkrider, about the pending legislation and the legal impact of regulating biosimilars. [read post]